The World is amidst the COVID-19 pandemic. The only prevention to the pandemic is Vaccine. The Efficacy of COVID-19 Vaccine is an important factor to be considered. Antibodies save a large number of lives every year. Antibodies work via preparing constantly the body’s regular defense. The immune system perceives and fends off the infections and microbes they target. Efficacy of the COVID-19 Vaccine is the hot topic of discussion in intellectual medical communities of the world. After the vaccination, if that body is subsequently presented with those infections that are caused by pathogens, the body is quickly prepared to destroy them and prevent the illness.
The thing that make the vaccines credible is its efficacy against the infection in the future to the vaccinated individual. All the scientists of the current era are struggling through the available resources. Different global organizations has calculated the efficacies of several vaccines clinically tried on the public. I shall discuss the different available vaccines efficacies against COVID-19. Now, here available multiple kinds of vaccines Globally.
The COVID-19 vaccine, BioNTech was made available for Emergency-Use-Authorization (EUA) and approved on December 11, 2020. The vaccines are manufactured by Pfizer. The official name of the vaccines is BNT162b2. It is the mRNA antibody that codes for the spike proteins of the viruses. Once administered, the cell produces the spike protein. It showed 95% of efficacy.
16 years & Plus
An efficacy pace of 94.5% is observed regarding Moderna. It is an mRNA anti-body vaccine. The vaccine was approved on December 19 2020 as EUA by FDA.
2 Doses, separated by 28 days.
18 years & Plus
3. AstraZeneca-University of Oxford
AstraZeneca and the University of Oxford declared undeniable levels of outcomes of their COVID-19 antibody. Brazil and UK exhibited an efficacy of up to 90% regarding AstraZeneca. Recently blood clotting/coagulation cases were reported after taking this vaccine. But AstraZeneca claimed this is of a lower percentage and not causing any lethality.
AstraZeneca delivered an essential investigation on March 25, 2021, that the efficacy of the vaccine is 76% against the suggested COVID-19.
2 Doses, 28 days apart
18 years & Plus
4. Johnson & Johnson
Johnson and Johnson developed a COVID-19 vaccine named Janssen. The company J&J claimed that this vaccine just requires a single dose. The CDC and US FDA recommended the resumption of the J&J/Janssen COVID-19 vaccine after a temporary pause. The efficacy for the vaccine is seen to be 66%.
18 years & Plus
5. Sputnik V
Russian Ministry of Health has registered the COVID-19 vaccine named “Gam-COVID-Vac” on August 11, 2020. Gamaleya Research Institute of Epidemiology and Microbiology has developed this Sputnik V (Gam-COVID-Vac) vaccine. Russia has approved the use of this vaccine in September 2020. An authentic source has claimed the efficacy of the vaccine is 91.6.
6. Sinovac Biotech
The vaccine is less efficacious. Brazil has been struck by COVID-19 terribly. The Government of Brazil has arranged a Chinese vaccine. Sinovac is a Beijing-based Bio-Pharmaceutical company. It surpasses the CoronaVac, which is not an active vaccine. Without the side effects of severe diseases, this vaccine affects virus particles. The efficacy for the respective vaccine is calculated as 50%.
The vaccine NVX-CoV2373 is protein-based and it is against Corona Virus. Novavax is a company that is Maryland-based. The vaccine was clear as 89% effective against the affected cells in March 2021. At the start of Clinical testing, antibiotics in high amounts were produced by the vaccine. The killer T-Cell can recognize the infected cells can destroy these cells before their side effects.
8. CanSino Biologics
The vaccine CanSino Biologics was co-developed along with the military of China. It has a 65.7% efficacy rate. That is based on an international analysis premier posted on Twitter on February 8, 2021, by Pakistani Health Advisor Dr. Faisal Sultan. With Russia, the ongoing trial is being planned to control if consumption of the second dose of vaccine of Russia Sputnik V along with CanSino would cause the better or same protection against the pandemic.
The Blogger Fiza Iqbal is an M.S. Life Sciences Scholar at a Public Sector University in Lahore PAKISTAN.